Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

5,200

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Metabolic Syndrome
Interventions
DRUG

Berberine

The tablet of berberine and placebo are both coated with white sugar and had the same appearance. Berberine tablet will be orally taken with a dose of 500mg twice daily

BEHAVIORAL

Healthy lifestyle intervention

"Healthy lifestyle intervention will be launched according to the Chinese guidelines on prevention of cardiovascular and metabolic diseases by Chinese Preventive Medical Association in 2019, including health lectures, health information promotion, health manual and so on."

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
collaborator

Chinese Society of Cardiology

OTHER

lead

Tang Yida

OTHER